CompletedPhase IInterventional

Phase 1 trial HMR code: 25-006

This is an early-stage medical study, known as Phase 1, codenamed HMR 25-006. It's looking for healthy female volunteers to help test a new treatment. In these types of studies, researchers check how safe a new treatment is and how the body handles it, often by using small doses first. The main aim is to see if it works as expected before it can be developed further. Due to rules about how some trials release information, the full details of what exactly is being tested and why are not available yet. These details will be made public within 30 months after the study has officially ended. If you're a healthy woman and interested in potentially helping medical science, this study might be for you.

At a glance

Status

Completed

Phase

Phase I

Sponsor

Medherant Limited

Enrolment target

Start

07 Oct 2025

Estimated completion

23 Feb 2026

Healthy volunteers

What is this study about?

This is a very early stage (Phase 1) clinical trial, which means it's one of the first times a new potential treatment is being tested in people. The main purpose of these early studies is to check for safety and how the body reacts to the new treatment, rather than to see if it cures a specific illness.

The study is called HMR 25-006 and it's looking for healthy volunteers. This is typical for Phase 1 trials – by testing in healthy individuals, researchers can get a clear picture of how the treatment behaves without the complication of an existing health condition.

At the moment, the full details about what the treatment is and which specific health area it might eventually help are not being shared publicly. This is sometimes allowed for various reasons, especially in very early research. However, a promise has been made that all the information will become available to the public within 30 months after the study has been completed. This helps ensure transparency in research as time goes on.

Key takeaways

It's an early-stage study (Phase 1) testing a new treatment.
It's looking for healthy female volunteers.
The full details of the study will be released later.
The main goal is to check safety and how the body reacts to the treatment.
You can withdraw from the study at any time.

Who may be eligible?

To be able to take part in this study, you must be a healthy woman. Being 'healthy' generally means you don't have any major ongoing medical conditions, you're not taking certain medications, and you meet other health checks that the study doctors will explain.

While the detailed reasons for who cannot join (exclusion criteria) are not yet public, they are usually related to ensuring your safety. For example, if you have certain health problems or are on specific treatments, it might not be safe for you to take part.

The study is open to adult women of any age. However, the study team will conduct thorough health checks to make sure it's safe for you specifically to participate.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

Are you a woman?
Are you generally in good health?
Are you an adult (any age)?
Are you able to attend clinic visits as required by the study?

Answer every question to see your result.

What does participation involve?

Since the full details of this trial are not yet public, we can only give general information about what taking part in a Phase 1 study usually involves. Typically, you would have an initial screening visit to check your health and make sure you're suitable. If you qualify, you would receive the study treatment, likely over one or more visits to the clinic.

This might involve taking medication (pills or injections), having blood tests, urine tests, and other checks to see how your body is reacting. You would also have follow-up appointments after the treatment to monitor your health. The exact number of visits, tests, and the total length of time you'd be involved will be explained by the study team if you express interest.

Potential risks and benefits

The main benefit for you in taking part in a Phase 1 study is contributing to medical science and helping to develop new potential treatments for the future. You may also receive payment for your time and travel. Potential risks, as with any medical treatment, can include side effects, which the study team will explain in detail. These can range from mild, like a headache, to more serious, though rare, reactions. It's very important to remember that you have the right to withdraw from the study at any time, for any reason, without it affecting your medical care.

Locations (1)

Some site locations are approximate. We're improving this — please verify with the trial team before travelling.

Hammersmith Medicines Research (HMR)
City only
London, United Kingdom

Common questions

What is a Phase 1 trial?

It's the very first time a new treatment is tested in humans, mainly to check for safety and how the body handles it.

Why can't I see all the details now?

Sometimes, for very new research, full details are kept private temporarily. They will be shared within 30 months after the study ends.

Who can take part in this study?

This study is looking for healthy female volunteers of any adult age.

Will I get paid for taking part?

Phase 1 trials often offer payment for your time and travel, but you should ask the study team for specific details.

Can I stop being in the study at any time?

Yes, you have the right to leave the study at any point, and your decision won't affect your medical care.

How to find out more

Gemma Clark

g.clark@medherant.co.uk +44 (0) 2476 323 060 Official trial record

Always speak to your GP or specialist before deciding to take part in a study.